New York A06087 mandates full coverage for multi-marker testing related to ovarian cancer for patients diagnosed with an ovarian adnexal mass.
New York A06087 amends the insurance law to require health insurance policies to fully cover multi-marker testing related to ovarian cancer for patients diagnosed with an ovarian adnexal mass. This coverage is exempt from annual deductibles and coinsurance, with the insurer bearing the full cost. The changes apply to policies issued, reissued, renewed, modified, or amended after the law takes effect.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.